Vaccines comprising innovative adjuvants are rapidly reaching advanced translational
stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID …

The self-assembly of low-molecular-weight building motifs into supramolecular polymers
has unlocked a new realm of materials with distinct properties and tremendous potential for …

Peptide‐based supramolecular therapeutics (PST) refer to those theranostic nanomedicines
based on peptide or peptide derivatives self‐assembly that are constructed in vitro or in vivo …

Nanomaterials are becoming important tools for vaccine development owing to their tunable
and adaptable nature. Unique properties of nanomaterials afford opportunities to modulate …

The development of subunit vaccine platforms has been of considerable interest due to their
good safety profile and ability to be adapted to new antigens, compared to other vaccine …

Vaccine efficacy determined within the controlled environment of a clinical trial is usually
substantially greater than real-world vaccine effectiveness. Typically, this results from …

Spanning from the mitigation of pathogenic diseases via protective immunity to the provision
of therapeutic solutions for other debilitating ailments, immune-based interventions have …

Self-assembled peptides have become a hot topic in research on new fishery-immersed
nanovaccines due to their physical and chemical properties and efficient carrying capacity …

Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified as a human
pathogenic virus in 2012 and is causing ongoing sporadic infections as well as outbreak …